2-Hydroxy-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline-2-carbonitrile

ID: ALA4860699

PubChem CID: 164616494

Max Phase: Preclinical

Molecular Formula: C20H28N2O3

Molecular Weight: 344.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OC)C1CC(O)(C#N)C(CC(C)C)CN1CC2

Standard InChI:  InChI=1S/C20H28N2O3/c1-13(2)7-15-11-22-6-5-14-8-18(24-3)19(25-4)9-16(14)17(22)10-20(15,23)12-21/h8-9,13,15,17,23H,5-7,10-11H2,1-4H3

Standard InChI Key:  DGLPXLLFZLJOLW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   27.5691  -14.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1607  -13.4033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7479  -14.1132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.3137  -10.9075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3125  -11.7349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0273  -12.1477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0255  -10.4949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7408  -10.9039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7396  -11.7369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1803  -10.9060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4588  -10.4862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1791  -11.7391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4532  -12.1490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4453  -12.9780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8875  -12.9935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8972  -12.1581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5975  -13.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3163  -13.0085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0263  -13.4284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3249  -12.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5977  -12.1468    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.8836  -11.7338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5992  -10.4953    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.5990   -9.6703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9773  -14.8282    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 11  1  0
  9 13  1  0
 12 10  1  0
 10 11  1  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 14  2  1  0
  2 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
  5 21  1  0
 21 22  1  0
  4 23  1  0
 23 24  1  0
  1 25  3  0
M  END

Alternative Forms

  1. Parent:

    ALA4860699

    ---

Associated Targets(non-human)

Slc18a2 Synaptic vesicular amine transporter (631 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 344.46Molecular Weight (Monoisotopic): 344.2100AlogP: 2.92#Rotatable Bonds: 4
Polar Surface Area: 65.72Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.93CX Basic pKa: 7.20CX LogP: 2.44CX LogD: 2.22
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.85Np Likeness Score: 0.72

References

1. Yang Y, Yu D, Zhu X, Du G, Wang W, Zou F, Wang H, Zhang R, Ye L, Tian J..  (2021)  Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitors.,  224  [PMID:34329999] [10.1016/j.ejmech.2021.113718]

Source